Bristol-Myers Squibb Company News Headlines

BMY 
$49.46
*  
0.35
 negative 
0.71%
Get BMY Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Five Prime Therapeutics (FPRX) Is Rising On BMY Collaboration News
3/17/2014 9:50:00 AM - RTT News

Five Prime And Bristol-Myers Squibb To Collaborate On Immuno-oncology
3/17/2014 9:40:00 AM - RTT News

U.S. Hot Stocks: Hot Stocks to Watch
3/17/2014 9:22:00 AM - Dow Jones Business News

IDIX Sues GILD, ICPT Shows POISE, Watch Out For BDSI, SCMP Takes A Hit
3/16/2014 11:02:00 PM - RTT News

MultiStem Overshadows Q4 Loss at Athersys - Analyst Blog
3/14/2014 3:31:01 PM - Zacks.com

Johnson & Johnson: A Safe Bet For Conservative Investors
3/12/2014 2:39:00 PM - Seeking Alpha

Pernix Therapeutics Appoints Terence Novak As COO
3/10/2014 12:23:00 PM - RTT News

Sangamo Soars on Positive Data - Analyst Blog
3/7/2014 12:50:01 PM - Zacks.com

Stock Market News for March 07, 2014 - Market News
3/7/2014 11:06:01 AM - Zacks.com

Pipeline Progress at Bristol-Myers - Analyst Blog
3/6/2014 12:50:01 PM - Zacks.com

Notable ETF Inflow Detected - IYH, PFE, BMY, UNH
3/6/2014 12:24:08 PM - BNK Invest

Repligen Q4 Profit Down; Guides FY14 - Quick Facts
3/6/2014 8:01:00 AM - RTT News

Merck, Bristol-Myers Report Positive Data
3/5/2014 1:45:00 PM - Dow Jones Business News

Merck, Bristol-Myers Report Positive Data on Investigational HIV Drugs
3/5/2014 1:35:00 PM - Dow Jones Business News

Bristol-Myers Plans Late-Stage Tests on Yervoy as Lung-Cancer Treatment
3/4/2014 6:52:00 PM - Dow Jones Business News

AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog
3/4/2014 6:10:01 PM - Zacks.com

Daily Dividend Report: SXT, BMY, KRFT, AMAT, MR
3/4/2014 3:59:48 PM - BNK Invest

Wider-Than-Expected Q4 Loss at Cadence Pharma - Analyst Blog
3/4/2014 2:44:01 PM - Zacks.com

Bristol-Myers To Present At Cowen And Co. Conference; Webcast At 10:00 AM ET
3/4/2014 9:00:00 AM - RTT News

Harsco CEO Patrick Decker Steps Down To Join Xylem In Same Position
3/3/2014 8:08:00 AM - RTT News

The New #223 Most Shorted S&P 500 Component: Bristol-Myers Squibb
2/27/2014 4:19:21 PM - BNK Invest

FDA Clears AstraZeneca's Myalept - Analyst Blog
2/26/2014 6:00:01 PM - Zacks.com

Noteworthy ETF Inflows: FVD, GPS, WAG, BMY
2/26/2014 12:12:21 PM - BNK Invest

Compugen: A Wealth Creation Opportunity In The Making
2/26/2014 9:19:00 AM - Seeking Alpha

FDA Designation for Bristol-Myers Candidate - Analyst Blog
2/25/2014 6:20:01 PM - Zacks.com